Literature DB >> 32315222

A CRISPR Odyssey into Cancer Immunotherapy.

Elizabeth Delgado1,2,3, Samira Kiani1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32315222      PMCID: PMC8935473          DOI: 10.1089/crispr.2020.29090.ede

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


× No keyword cloud information.
  4 in total

1.  CRISPR-engineered T cells in patients with refractory cancer.

Authors:  Edward A Stadtmauer; Joseph A Fraietta; Simon F Lacey; Carl H June; Megan M Davis; Adam D Cohen; Kristy L Weber; Eric Lancaster; Patricia A Mangan; Irina Kulikovskaya; Minnal Gupta; Fang Chen; Lifeng Tian; Vanessa E Gonzalez; Jun Xu; In-Young Jung; J Joseph Melenhorst; Gabriela Plesa; Joanne Shea; Tina Matlawski; Amanda Cervini; Avery L Gaymon; Stephanie Desjardins; Anne Lamontagne; January Salas-Mckee; Andrew Fesnak; Donald L Siegel; Bruce L Levine; Julie K Jadlowsky; Regina M Young; Anne Chew; Wei-Ting Hwang; Elizabeth O Hexner; Beatriz M Carreno; Christopher L Nobles; Frederic D Bushman; Kevin R Parker; Yanyan Qi; Ansuman T Satpathy; Howard Y Chang; Yangbing Zhao
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

2.  Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.

Authors:  Shayesteh R Ferdosi; Radwa Ewaisha; Farzaneh Moghadam; Sri Krishna; Jin G Park; Mo R Ebrahimkhani; Samira Kiani; Karen S Anderson
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

Review 3.  Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection.

Authors:  Chun-Hao Huang; Ko-Chuan Lee; Jennifer A Doudna
Journal:  Trends Cancer       Date:  2018-06-13

4.  Directed evolution of CRISPR-Cas9 to increase its specificity.

Authors:  Jungjoon K Lee; Euihwan Jeong; Joonsun Lee; Minhee Jung; Eunji Shin; Young-Hoon Kim; Kangin Lee; Inyoung Jung; Daesik Kim; Seokjoong Kim; Jin-Soo Kim
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

  4 in total
  1 in total

Review 1.  Targeting Cancer with CRISPR/Cas9-Based Therapy.

Authors:  Katarzyna Balon; Adam Sheriff; Joanna Jacków; Łukasz Łaczmański
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.